LYFELINEZ LTD
Company number 13588796 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
LYFELINEZ LTD - Analysis Report
Company Number: 13588796
Analysis Date: 2025-07-29 12:24 UTC
Financial Health Assessment Report for LYFELINEZ LTD
1. Financial Health Score: D
Explanation:
The company shows significant signs of financial distress despite some recent improvement. While net assets have turned positive in 2024, the heavy long-term liabilities overshadow current assets and working capital. This grade reflects a fragile financial position requiring urgent attention to avoid worsening conditions.
2. Key Vital Signs
| Metric | 2024 Value | Interpretation |
|---|---|---|
| Fixed Assets | £761 | Minimal investment in long-term assets; typical for a micro-entity but limits collateral base. |
| Current Assets | £16,566 | Improved sharply from prior years; indicates better liquidity potential. |
| Current Liabilities | £13,179 | Increase from 2023 but still manageable relative to current assets. |
| Net Current Assets (Working Capital) | £3,387 | Positive working capital signals healthier day-to-day operational liquidity ("healthy cash flow"). |
| Creditors due after 1 year (Long-Term Liabilities) | £68,851 | Substantial long-term debt burden; a "symptom of distress" that threatens solvency. |
| Net Assets (Shareholders’ Funds) | £64,703 | Positive net assets in 2024, a significant turnaround from prior negative figures. |
| Share Capital | £100 | Very low equity base; typical for small startups but increases financial risk. |
| Employees | 1 | Very small operational scale; limited human resource base. |
3. Diagnosis
LYFELINEZ LTD exhibits mixed financial health with critical warning signs. The 2024 accounts show a recovery in net assets and working capital compared to previous years, indicating some operational or financial improvements—akin to a patient showing early signs of recovery after distress.
However, the company carries a large long-term liability (£68,851) far exceeding current assets and fixed assets combined. This imbalance suggests the company is relying heavily on debt financing, which is a "chronic condition" that could lead to liquidity crises if cash flows falter.
The minimal fixed assets and small employee base further limit the company’s ability to generate steady income or collateralize debt. The positive net current assets (working capital) is encouraging, indicating that short-term obligations can currently be met without stress.
The company’s micro-entity status and small scale imply limited operational complexity but also restrict access to larger financing options. The controlling shareholder/director has full control, which can expedite decision-making but also concentrates risk.
4. Recommendations
Debt Restructuring:
Engage with creditors to restructure or refinance long-term debt. Reducing interest burden and extending maturities can improve financial breathing space.Increase Equity Base:
Consider raising additional equity capital to strengthen the financial foundation. This could involve new investors or increased shareholder contributions to reduce reliance on debt.Improve Cash Flow Management:
Focus on accelerating receivables, managing payables efficiently, and controlling operational expenses to maintain healthy working capital.Asset Utilization and Growth Strategy:
Explore opportunities to invest in fixed assets or intellectual property that can improve production capacity or product differentiation in the food manufacturing sector (SIC 10890).Regular Financial Monitoring:
Implement rigorous monthly financial reviews to detect early symptoms of cash flow distress and adjust operations promptly.Professional Advice:
Seek advice from financial advisors or insolvency practitioners proactively to prepare contingency plans if financial conditions worsen.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.